Executive Management Team

Introducing the Amarin Corporation Executive Team

Karim Mikhail

President and Chief Executive Officer

Karim Mikhail became President and CEO of Amarin on 1st August 2021, having joined the company in 2020 as SVP and Commercial Head Europe. Mr. Mikhail joined Amarin from THEODON, a global commercial strategy consultancy he founded in 2018. Prior to that, he was with Merck for 22 years, in a career spanning seven different countries across three continents, including being commercial leader for Merck’s $4 billion lipid franchise. Mr. Mikhail was also chief marketing officer for Europe Middle East & Africa and COO for emerging markets.

Laurent Abuaf

Senior Vice President & President of Europe

Laurent Abuaf joined Amarin on August 23, 2021, as Senior Vice President and President of Europe. Mr. Abuaf is responsible for driving Amarin’s European launch activities and commercial expansion plans. He has nearly 20 years of global pharmaceutical commercial experience, most recently serving as AstraZeneca’s UK President.
Mr. Abuaf brings a wealth of local, regional and global strategic management experience across small, medium and large markets in both Europe and Asia, including cardiometabolic experience, having contributed to the successful launch of other major cardiovascular treatments.

European Leadership Team

Hakima Hannachi, Head of Medical Affairs

David Jakouloff, Head of Market Access

Christos Papadopoulos, General Manager for Central Eastern European (CEE)

Tatyana Tyx, Head of Marketing

Angelos Hartsiotis, Head of Commercial Trade and Pharmacy Operations

Peter Overgaard, VP Human Resources

Patrik Geisel, Head of Digital

Sven Voet, Head of Communications

Sebastian Goebel, Compliance and Data Privacy Officer

Tamara Barghout, EU Launch Lead (Sr. Director)

Angelos Baxevanis, Head of Strategy and Transformation

Olivier Delannoy, EU Vice President Business Operations & Commercial Excellence